Quantitative analysis for Takeda Pharmaceutical Company Limited (TAK) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 31 signals analyzed (27 differentiated alt-data).
TAK stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $16.39 | $16.24 | $16.30 |
| 2026-05-11 | $16.54 | $16.28 | $16.36 |
| 2026-05-21 | $16.50 | $16.24 | $16.48 |
| 2026-06-03 | $15.09 | $14.84 | $15.03 |
| 2026-06-15 | $15.88 | $15.75 | $15.77 |
| 2026-06-26 | $15.98 | $15.75 | $15.91 |
| 2026-07-09 | $16.69 | $16.57 | $16.61 |
| 2026-07-21 | $17.25 | $17.03 | $17.23 |
| 2026-07-31 | $17.19 | $16.93 | $17.09 |
| 2026-08-12 | $17.47 | $17.35 | $17.41 |
| 2026-08-24 | $18.26 | $18.11 | $18.24 |
| 2026-09-03 | $18.84 | $18.52 | $18.71 |
How Takeda Pharmaceutical Company Limited stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ARGX | argenx SE | $49.8B | — |
| HLN | Haleon plc | $41.2B | — |
| TEVA | Teva Pharmaceutical Industries Limited | $40.0B | — |
| ONC | BeOne Medicines Ltd. | $33.0B | — |
View all Health Care stocks by valuation and signals →
Takeda Pharmaceutical Company Limited (TAK) scores Unrated (50.0), with no measured dimension below 72. Its highest are technicals at 91, analyst consensus at 74, valuation at 72, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 91 |
| analyst consensus | 74 |
| valuation | 72 |
StoQuant analyzes 31 signals (27 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Takeda Pharmaceutical Company Limited (TAK): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/TAK"><img src="https://stoquant.com/badge/TAK.svg" alt="Takeda Pharmaceutical Company Limited (TAK) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.